Singulex closed a round of $19 million in Q4 2008. Our investors include:
Fisk Ventures LLC is a private venture capital fund of H. Fisk Johnson, Ph.D., President & CEO of S.C. Johnson & Son.
OrbiMed is one of the world’s largest fully-dedicated healthcare asset management firms, with over $6 billion in assets under management. Since inception of its private equity investment activities in 1993, OrbiMed has successfully made investments in over 70 companies across a wide range of therapeutic categories and stages of development. OrbiMed’s investment team includes over 20 experienced professionals with backgrounds in science, medicine, finance and law.
JAFCO is a global investment management company headquartered in Tokyo. For more than 35 years, JAFCO has invested in exceptional companies with differenciated technology in sectors including electronics, IT services, software, distribution and biotechnology. JAFCO successfully maintains a well-balanced protfolio by raising corporate values of investee companies and establishing a value chain of private equity investment.
Prolog is a venture capital firm specializing in life sciences. The fund has supported more than 20 companies since its launch in 2001. Prolog invests in traditional healthcare opportunities as well as companies in emerging areas such as nutrition, wellness, and green technology.
For more information about our company, please contact us.